We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
Cap. Flow
+$425M
Cap. Flow %
0.92%
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$128M
2
BKR icon
Baker Hughes
BKR
+$26.7M
3
IQV icon
IQVIA
IQV
+$14.5M
4
OKE icon
Oneok
OKE
+$14.3M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.2M

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$114M
2
RAI
Reynolds American Inc
RAI
+$88.6M
3
BHI
Baker Hughes
BHI
+$41.6M
4
WFM
Whole Foods Market Inc
WFM
+$26.7M
5
UNH icon
UnitedHealth
UNH
+$22.8M

Sector Composition

Rank Sector Weight
1 Financials 16.64%
2 Technology 15.8%
3 Healthcare 13.57%
4 Industrials 10.87%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHN
2151
DELISTED
Achillion Pharmaceuticals
ACHN
$707K ﹤0.01%
157,396
+980
+0.6% +$4.35K
PDLI
2152
DELISTED
PDL BioPharma, Inc.
PDLI
$706K ﹤0.01%
208,346
+2,596
+1% +$7.22K
FND icon
2153
Floor & Decor
FND
$6.13B
$705K ﹤0.01%
18,109
+8,238
+83% +$306K
RVNC
2154
DELISTED
Revance Therapeutics, Inc.
RVNC
$705K ﹤0.01%
25,603
+270
+1% +$6.54K
PRTK
2155
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$704K ﹤0.01%
28,061
+959
+4% +$22.3K
BBG
2156
DELISTED
Bill Barrett Corp
BBG
$704K ﹤0.01%
164,085
+3,130
+2% +$10.4K
LJPC
2157
DELISTED
La Jolla Pharmaceutical Company
LJPC
$704K ﹤0.01%
20,247
+235
+1% +$7.56K
MSEX icon
2158
Middlesex Water
MSEX
$1.08B
$703K ﹤0.01%
17,914
-20
-0.1% -$777
AXDX
2159
DELISTED
Accelerate Diagnostics
AXDX
$699K ﹤0.01%
3,114
+28
+0.9% +$6.88K
NEO icon
2160
NeoGenomics
NEO
$1.96B
$694K ﹤0.01%
62,375
+875
+1% +$8.52K
THR
2161
DELISTED
Thermon Group Holdings
THR
$691K ﹤0.01%
38,423
+90
+0.2% +$1.58K
ITCI
2162
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$689K ﹤0.01%
43,676
+380
+0.9% +$5.58K
CNR
2163
DELISTED
Cornerstone Building Brands, Inc.
CNR
$688K ﹤0.01%
44,097
+760
+2% +$12.6K
SGY
2164
DELISTED
Stone Energy
SGY
$685K ﹤0.01%
23,586
+674
+3% +$16.2K
CONN
2165
DELISTED
Conn's Inc.
CONN
$684K ﹤0.01%
24,281
+10
+0% +$210
MBWM icon
2166
Mercantile Bank Corp
MBWM
$1.04B
$678K ﹤0.01%
19,430
+100
+0.5% +$3.17K
CHUY
2167
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$678K ﹤0.01%
32,209
+790
+3% +$16.8K
FMI
2168
DELISTED
Foundation Medicine, Inc.
FMI
$678K ﹤0.01%
16,868
+240
+1% +$9.26K
CRC
2169
DELISTED
California Resources Corporation
CRC
$677K ﹤0.01%
64,748
+4,625
+8% +$37K
INSW icon
2170
International Seaways
INSW
$4.76B
$676K ﹤0.01%
34,322
+444
+1% +$9.07K
SPOK icon
2171
Spok Holdings
SPOK
$228M
$676K ﹤0.01%
44,027
+870
+2% +$14.2K
GSBC icon
2172
Great Southern Bancorp
GSBC
$874M
$675K ﹤0.01%
12,123
+120
+1% +$6.16K
ACET
2173
DELISTED
Aceto Corp
ACET
$674K ﹤0.01%
60,007
+950
+2% +$13.1K
PCBK
2174
DELISTED
Pacific Continental Corp
PCBK
$674K ﹤0.01%
25,026
+100
+0.4% +$2.47K
CTT
2175
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$671K ﹤0.01%
53,192
+1,175
+2% +$13.7K
85 86
87
88 89

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RhumbLine Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
  • RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
  • RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
  • RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
  • RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
  • RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.